{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:29:20Z","timestamp":1792002560388,"version":"4.4.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Pancreas"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The aim of this study was to investigate survival in patients who received celiac plexus neurolysis (CPN) compared with patients who received opioids.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The Surveillance, Epidemiology and End Results\u2013Medicare database was used to identify patients older than 65 years diagnosed with pancreatic cancer between 2007 and 2015. We used claims data to identify patients with a history of CPN and opioid use within 1 year of diagnosis, and other demographic, clinical, and treatment variables. Kaplan-Meier analyses and inverse propensity-weighted adjusted Cox proportional hazard ratios were used to evaluate survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We identified 648 patients who underwent CPN (19.0%) compared with 2769 patients who received opioids (81.0%). The median survival and interquartile range for patients who received CPN was 4.0 months (2.0\u20138.0 months) compared with 7.0 months (3.0\u201312.0 months) for opioid users (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001). After adjusting for confounders and propensity score, the patients who received CPN showed worsened survival (hazard ratio, 1.69; 95% confidence interval, 1.59\u20131.79).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Pancreatic cancer patients who underwent CPN had decreased survival compared with opioid users. This suggests that opioid sparing methods to reduce pancreatic cancer pain may actually be harmful. Future prospective studies should investigate whether other opioid sparing therapies impact pancreatic cancer survival.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mpa.0000000000001992","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T14:00:13Z","timestamp":1649685613000},"page":"153-158","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Celiac Plexus Neurolysis Is Associated With Decreased Survival in Patients With Pancreatic Cancer"],"prefix":"10.1097","volume":"51","author":[{"given":"Haley M.","family":"Zylberberg","sequence":"first","affiliation":[{"name":"Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Nagula","sequence":"additional","affiliation":[{"name":"Gastroenterology, Icahn School of Medicine at Mount Sinai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila D.","family":"Rustgi","sequence":"additional","affiliation":[{"name":"Division of Digestive and Liver Disease, Columbia University Irving Medical Center, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Aronson","sequence":"additional","affiliation":[{"name":"Gastroenterology, Icahn School of Medicine at Mount Sinai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Kessel","sequence":"additional","affiliation":[{"name":"Gastroenterology, Icahn School of Medicine at Mount Sinai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil A.","family":"Kumta","sequence":"additional","affiliation":[{"name":"Gastroenterology, Icahn School of Medicine at Mount Sinai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"DiMaio","sequence":"additional","affiliation":[{"name":"Gastroenterology, Icahn School of Medicine at Mount Sinai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee L.","family":"Lucas","sequence":"additional","affiliation":[{"name":"Gastroenterology, Icahn School of Medicine at Mount Sinai"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20250812","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"bib2-20250812","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","article-title":"Pancreatic cancer","volume":"378","year":"2011","journal-title":"Lancet"},{"key":"bib3-20250812","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s10620-017-4488-z","article-title":"Pain in patients with pancreatic cancer: prevalence, mechanisms, management and future developments","volume":"62","year":"2017","journal-title":"Dig Dis Sci"},{"key":"bib4-20250812","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.21873\/anticanres.14133","article-title":"Pathogenesis and treatment of pancreatic cancer related pain","volume":"40","year":"2020","journal-title":"Anticancer Res"},{"issue":"2 Suppl","key":"bib6-20250812","first-page":"S105","article-title":"Opioid complications and side effects","volume":"11","year":"2008","journal-title":"Pain Physician"},{"key":"bib7-20250812","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.3748\/wjg.v20.i9.2186","article-title":"Celiac plexus neurolysis in the management of unresectable pancreatic cancer: when and how?","volume":"20","year":"2014","journal-title":"World J Gastroenterol"},{"key":"bib8-20250812","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/MCG.0b013e3181bb854d","article-title":"Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer","volume":"44","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"bib9-20250812","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/pme.12176","article-title":"Celiac plexus neurolysis for abdominal cancer pain: a systematic review","volume":"14","year":"2013","journal-title":"Pain Med"},{"key":"bib10-20250812","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1007\/s10620-008-0651-x","article-title":"EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: a meta-analysis and systematic review","volume":"54","year":"2009","journal-title":"Dig Dis Sci"},{"key":"bib11-20250812","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00000658-199305010-00004","article-title":"Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial","volume":"217","year":"1993","journal-title":"Ann Surg"},{"key":"bib12-20250812","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gie.2020.01.011","article-title":"Efficacy of EUS-guided celiac plexus neurolysis compared with medication alone for unresectable pancreatic cancer in the oxycodone\/fentanyl era: a prospective randomized control study","volume":"92","year":"2020","journal-title":"Gastrointest Endosc"},{"key":"bib13-20250812","first-page":"E357","article-title":"Impact of celiac plexus neurolysis on survival in patients with unresectable pancreatic cancer: a retrospective, propensity score matching analysis","volume":"20","year":"2017","journal-title":"Pain Physician"},{"key":"bib14-20250812","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jama.291.9.1092","article-title":"Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial","volume":"291","year":"2004","journal-title":"JAMA"},{"key":"bib15-20250812","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1200\/JCO.2010.32.2750","article-title":"Randomized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer","volume":"29","year":"2011","journal-title":"J Clin Oncol"},{"key":"bib16-20250812","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.gie.2014.12.036","article-title":"Impact of celiac neurolysis on survival in patients with pancreatic cancer","volume":"82","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"bib17-20250812","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"bib18-20250812","doi-asserted-by":"crossref","first-page":"21","DOI":"10.14715\/cmb\/2019.65.7.5","article-title":"Effects of fentanyl on pancreatic cancer cell proliferation and cancer stem cell differentiation","volume":"65","year":"2019","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"bib19-20250812","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.amjsurg.2007.02.026","article-title":"Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas","volume":"195","year":"2008","journal-title":"Am J Surg"},{"key":"bib20-20250812","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.ejca.2011.10.035","article-title":"Comorbidity, age and overall survival in patients with advanced pancreatic cancer\u2014results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placebo","volume":"48","year":"2012","journal-title":"Eur J Cancer"},{"key":"bib21-20250812","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.gastro.2008.09.029","article-title":"Pancreatic neuropathy and neuropathic pain\u2014a comprehensive pathomorphological study of 546 cases","volume":"136","year":"2009","journal-title":"Gastroenterology"},{"key":"bib22-20250812","first-page":"211","article-title":"Psychosocial distress in patients treated for cancer pain: a prospective observational study","volume":"6","year":"2010","journal-title":"J Opioid Manag"},{"key":"bib23-20250812","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nrn1914","article-title":"Cancer pain and its impact on diagnosis, survival and quality of life","volume":"7","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"bib24-20250812","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1470-2045(04)01597-9","article-title":"Stress, depression, the immune system, and cancer","volume":"5","year":"2004","journal-title":"Lancet Oncol"},{"key":"bib25-20250812","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.gie.2017.01.041","article-title":"EUS-guided celiac ganglia neurolysis: a clinical and human cadaver study (with video)","volume":"86","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"bib26-20250812","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cgh.2018.08.040","article-title":"Combined celiac ganglia and plexus neurolysis shortens survival, without benefit, vs plexus neurolysis alone","volume":"17","year":"2019","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000001992","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:05:06Z","timestamp":1754957106000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000001992"}},"subtitle":["A Propensity Score Analysis"],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000001992","relation":{},"ISSN":["1536-4828","0885-3177"],"issn-type":[{"value":"1536-4828","type":"electronic"},{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}